Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CHRDL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CACUL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
GFRA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITIH5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP1S3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFIA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMAN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PGBD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NPAS4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRPRA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NIPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDXK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STRBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM199X - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NIPA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on